Kaori Morimoto

Carbonic Anhydrase Inhibitors:  DNA Cloning and Inhibition Studies of the α-Carbonic Anhydrase from <i>Helicobacter pylori</i>, A New Target for Developing Sulfonamide and Sulfamate Gastric Drugs

Isao Nishimori, Tomoko Minakuchi, Kaori Morimoto et al. · Journal of Medicinal Chemistry · 2006 · 167 citations · Full text

Medicine, Molecular Biology, Pharmacology +16

Oseltamivir (Tamiflu) Is a Substrate of Peptide Transporter 1

Takuo Ogihara, Takashi Kano, Tamae Wagatsuma et al. · Drug Metabolism and Disposition · 2009 · 53 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Effect of Knockdown of Ezrin, Radixin, and Moesin on P-Glycoprotein Function in HepG2 Cells

Takashi Kano, Sho Wada, Kaori Morimoto et al. · Journal of Pharmaceutical Sciences · 2011 · 44 citations

Life Sciences, Molecular Biology, Pharmacology +6

Carbonic anhydrase inhibitors: Cloning and sulfonamide inhibition studies of a carboxyterminal truncated α-carbonic anhydrase from Helicobacter pylori

Isao Nishimori, Daniela Vullo, Tomoko Minakuchi et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 40 citations · Full text

Life Sciences, Biochemistry, Pharmacology +9

Hepatocyte Nuclear Factor 1 Alpha and 4 Alpha are Factors Involved in Interindividual Variability in the Expression of UGT1A6 and UGT1A9 but not UGT1A1, UGT1A3 and UGT1A4 mRNA in Human Livers††This work was supported by grants-in-aid from the Ministry of Health, Labor and Welfare of Japan (Health and Labor Sciences Research Grants, Research on Human genome, Tissue Engineering; Health and Labor Sciences Research Grants, Risk Analysis Research on Food and Pharmaceuticals), and was partially supported by grants (18890044 and 17790112) from the Ministry of Education, Sciences, Sports and Culture of Japan.

Sasitorn Aueviriyavit, Tomomi Furihata, Kaori Morimoto et al. · Drug Metabolism and Pharmacokinetics · 2007 · 39 citations

Life Sciences, Biochemistry, Molecular Biology +11